Scientists are working on new gene engineering method that could eventually allow us to grow our own organs for transplants.
New way to diagnose disease and predict patient outcomes simply by measuring unbelievably small changes in interactions between molecules inside the body.
A paper published by Craig Venter and colleagues has come under fire, with geneticists suggesting that it doesn’t demonstrate what it claims.
NewLink Genetics (NLNK) has reported positive data for a phase 2 study, reinforcing the success of the company within the market.
Scientists in the US have discovered a potential new treatment for psoriasis in humans, by using fire ant venom toxin in mice.
The drug inventing world can be a dog eat dog world, we take a look at the top tricks used by drug makers to squeeze the most money out of their inventions.
Scientists have developed a new method for loading DNA into sequencing wells with orders of magnitude higher efficiencies.
Researchers have shown the mechanisms by which cellular nuclei reach their position within muscle cells.
Despite a dry spell of biopharma mergers and acquisitions as of late, the acquisition of Kite Pharma (KITE) by Gilead Sciences (GILD) has caused a stir.
MSD has re-entered the RNA field by acquiring German biotech, Rigontech.
New DNA evidence has been discovered that proves the existence of female Viking warriors, in turn proving that war was not an exclusive male practice.
Genomic information company, WuXi NextCODE (WXNC) has announced that it has closed on $240 million in Series B financing, led by Sequoia.
An exciting new cancer treatment could soon be on the horizon that can produce better results whilst being less harmful to the body.
Sarepta Therapeutics is one company that has benefited most from an FDA shift in recent years, and it could soon be receiving more.
A new technique could eventually help delay the onset of Parkinson’s disease, Alzheimer’s disease and other age-related diseases in humans.